Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Carcinoma, Islet Cell / drug therapy*
• Carcinoma, Islet Cell / pathology
• Cell Differentiation
• Drug Resistance, Neoplasm / drug effects
• Drug Resistance, Neoplasm / physiology*
• Humans
• Male
• Middle Aged
• Neoplasm Staging
• Pancreatic Neoplasms / drug therapy*
• Pancreatic Neoplasms / pathology
• Protein Kinase Inhibitors / therapeutic use*
• TOR Serine-Threonine Kinases / antagonists & inhibitors*